UNCY Stock Analysis: Buy, Sell, or Hold?
UNCY - Unicycive Therapeutics, Inc. Common Stock
$7.13
-1.08 (-13.15%)
▼
5d:
+4.09%
30d:
+0.85%
90d:
+7.54%
BUY
HIGH Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When UNCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: UNCY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: UNCY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.31
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UNCY is currently trading at $7.13, which is considered slightly low relative to its 30-day fair value range of $7.02 to $7.85. The stock's valuation (Forward PE: 1.2) is in line with its historical norms (1.1). At these levels, the market is pricing in 3.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, UNCY is in a uptrend. Immediate support is located at $6.65, while resistance sits at $8.02. Short-term momentum is weak, with the stock down 13.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.30 (+479.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UNCY is in a uptrend. Immediate support is located at $6.65, while resistance sits at $8.02. Short-term momentum is weak, with the stock down 13.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.30 (+479.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.02 -
$7.85
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-13.2%)
- BULLISH: Trading 479.2% below Wall St target ($41.30)
- NEUTRAL: Market pricing in 3.4% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$7.02 -
$7.85
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.65
Resistance Level
$8.02
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.18
Wall Street Target
$41.30
(+479.2%)
Valuation Premium vs History
+3.4% premium
PE vs Historical
1.2 vs 1.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$7.37
(+3%)
2-Year Target
$7.62
(+7%)
3-Year Target
$7.88
(+11%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
PE COMPRESSION
$7.34
(+3%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 28, 2026 1:04 PM ET
Data refreshes hourly during market hours. Next update: 2:04 PM
Data refreshes hourly during market hours. Next update: 2:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UNCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$257 | 60 BUY |
